Abiopharma

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics USA - English APAC - English USA - English

Fifth Third Announces Transfer of Listing of Common Stock to the New York Stock Exchange

Welltower Board of Directors Approves 15% Increase in Quarterly Dividend to $0.85 per Share

OpenPayd Targets Nasdaq Listing at Unicorn Valuation

IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in embolization-eligible unresectable liver cancer in EMERALD-3 Phase III trial

Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy

Barings BDC, Inc. Announces Early Termination of Sierra Credit Support Agreement and $67.0 Million Payment From Barings LLC

Optimum Launches Effort to Drive a Consensual Repositioning of its Capital Structure

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026